Your browser doesn't support javascript.
A case report: Successful management of pulmonary aspergillosis associated with COVID ‐ 19 ARDS
Journal of Experimental and Clinical Medicine (Turkey) ; 39(2):563-565, 2022.
Article in English | Scopus | ID: covidwho-2146820
ABSTRACT
The recent global outbreak of coronavirus disease-19, also known as COVID-19, has infected more than 142 million people worldwide, causing more than 3 million deaths. It has been shown that up to 40% of hospitalized COVID-19 patients may develop ARDS. Although not proven, anti-inflammatory and anti-cytokine treatments are recommended to suppress the cytokine storm that develops in the early stages of the disease.In this case report, a case of pulmonary aspergillus developed as a complication of treatment for ARDS caused by covid 19 in a 50-year-old male patient will be presented in the light of current literature. © 2022 Ondokuz Mayis Universitesi. All rights reserved.
Keywords

Full text: Available Collection: Databases of international organizations Database: Scopus Type of study: Case report Language: English Journal: Journal of Experimental and Clinical Medicine (Turkey) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Scopus Type of study: Case report Language: English Journal: Journal of Experimental and Clinical Medicine (Turkey) Year: 2022 Document Type: Article